BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18611529)

  • 21. Postantibiotic effect and postantibiotic sub-mic effect of dirithromycin and erythromycin against respiratory tract pathogenic bacteria.
    Dornbusch K; Olofsson C; Holm S
    APMIS; 1999 May; 107(5):505-13. PubMed ID: 10335955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides.
    Braga PC
    J Chemother; 2002 Apr; 14(2):115-31. PubMed ID: 12017366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Resistance to macrolide antibiotics found in methicillin-resistant Japanese clinical isolates of Staphylococcus aureus in 1996].
    Nakamura A; Taniguchi K; Tsurubuchi K; O'Hara K; Sawai T
    Jpn J Antibiot; 1998 Jul; 51(7):494-500. PubMed ID: 9755433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.
    Maskell JP; Sefton AM; Williams JD
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():19-24. PubMed ID: 2154433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting.
    Alós JI; Aracil B; Oteo J; Torres C; Gómez-Garcés JL
    J Antimicrob Chemother; 2000 May; 45(5):605-9. PubMed ID: 10797081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
    Dubreuil L; Devos J; Romond C; Bryskier A
    Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial activity of josamycin against erythromycin-resistant staphylococci as compared to roxythromycin and clarithromycin.
    Guggenbichler JP; Georgopoulos A; Scharrer P; Kobilansky C; Mühlbacher J; Georgopoulos M; Dierich MP
    Infection; 1993; 21(4):259-61. PubMed ID: 8225634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
    Drabu YJ; Mehtar S; Blakemore PH
    Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid).
    Ling TK; Fung KS; Cheng AF
    Chemotherapy; 2001; 47(4):243-9. PubMed ID: 11399860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrolides resistance of common bacteria isolated from Taiwan.
    Chang SC; Chen YC; Luh KT; Hsieh WC
    Diagn Microbiol Infect Dis; 1995 Dec; 23(4):147-54. PubMed ID: 9407220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
    Neu HC; Chin NX; Gu JW
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():83-94. PubMed ID: 1328138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vitro evaluation of miokamycin: bactericidal activity against streptococci.
    Lacey RW; Lord VL; Howson GL
    J Antimicrob Chemother; 1984 Jan; 13(1):5-13. PubMed ID: 6607918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates.
    Descheemaeker P; Chapelle S; Lammens C; Hauchecorne M; Wijdooghe M; Vandamme P; Ieven M; Goossens H
    J Antimicrob Chemother; 2000 Feb; 45(2):167-73. PubMed ID: 10660498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
    Schlegel L; Merad B; Rostane H; Broc V; Bouvet A
    Clin Microbiol Infect; 2001 Jul; 7(7):362-6. PubMed ID: 11531981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
    King A; Phillips I
    Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the degree of susceptibility of Streptococcus pyogenes erythromycin-resistant strains to rokitamycin (a 16-membered macrolide) using the Epsilometer test.
    Crotti D; Rossetti R; Braga PC
    Drugs Exp Clin Res; 2004; 30(1):17-26. PubMed ID: 15134387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.
    Drabu YJ; Blakemore PH
    Drugs Exp Clin Res; 1990; 16(11):557-63. PubMed ID: 2151661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-antibiotic effects of RP 59500 with Staphylococcus aureus.
    Nougayrede A; Berthaud N; Bouanchaud DH
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():101-6. PubMed ID: 1399941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in vitro activity of A-56268.
    Sefton AM; Maskell JP; Yong FJ; Chi SJ; Williams JD
    Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):798-802. PubMed ID: 2975218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
    Bejuk D
    Acta Med Croatica; 2004; 58(4):301-6. PubMed ID: 15700686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.